Epidemiologic similarities in pediatric community-associated methicillin-resistant and methicillin-sensitive staphylococcus aureus in the San Francisco bay area

Journal of the Pediatric Infectious Diseases Society

Volumn 1, Issue 3, 2012, Pages 200-211

  Hsiang, Michelle S ^a   Shiau, Rita ^b   Nadle, Joelle ^c   Chan, Liana ^d   Lee, Brian ^e   Chambers, Henry F ^a   Pan, Erica ^b,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Francisco Department of Health   (United States)

^c California Emerging Infections Program   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL OAKLAND   (United States)

^f Alameda County Public Health Department   (United States)

Author keywords

Epidemiology; MRSA; MSSA; Pediatrics; S aureus

Indexed keywords

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CELLULITIS; CHI SQUARE TEST; CHILD; DIAGNOSTIC PROCEDURE; ECZEMA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TELEPHONE INTERVIEW;

EID: 84890332601     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis061     Document Type: Article

References (35)

1. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74.
2. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40: 1785-91.
3. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005; 41(Suppl 4):S269-72.
4. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168:1585-91.
5. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
6. Charlebois ED, Perdreau-Remington F, Kreiswirt B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
7. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 2004; 139:947-51; discussion 51-3.
8. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and-susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483-92.
9. CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR 2003; v52:793-5.
10. Zinderman CE, Conner B, Malakooti MA, LaMar JE, Armstrong A, Bohnker BK. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004; 10:941-4.
11. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillinresistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148: 249-57.
12. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-8.
13. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillinresistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002; 21:910-7.
14. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-44.
15. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 178:577-80.
16. Dietrich DW, Auld DB, Mermel LA. Communityacquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics 2004; 113: e347-52.
17. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998; 158:895-9.
18. Ragan P. Community-acquired MRSA infection: An update. JAAPA 2006; 19:24-9.
19. Hermos C, Shiau R, Hsiang M, Chambers HF, Pan E. Epidemiology of community-associated methicillin resistant Staphylococcus aureus in San Francisco children. J Pediatr Infect Dis 2009; 4:1305-7693.
20. McCarthy N, Giesecke J. Case-case comparisons to study causation of common infectious diseases. Int J Epidemiol 1999; 28:764-8.
21. David MZ, Mennella C, Mansour M, Boyle-Vavra S, Daum RS. Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: Risk factors and recurrence rates. J Clin Microbiol 2008; 46: 3222-7.
22. Buck JM, Como-Sabetti K, Harriman KH, et al. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis 2005; v11:1532-8.
23. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61.
24. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32.
25. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of communityacquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
26. Li M, Diep BA, Villaruz AE, et al. Evolution of virulence in epidemic community-associated methicillinresistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2009; 106:5883-8.
27. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillinsusceptible S. aureus infection: A prospective investigation. Clin Infect Dis 2007; 44:471-82.
28. Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R. Risk factors for community-associated Staphylococcus aureus infections: Results from parallel studies including methicillin-resistant and methicillinsensitive S. aureus compared to uninfected controls. Epidemiol Infect 2011; 139:419-29.
29. Miller LG, Kaplan SL. Staphylococcus aureus: A community pathogen. Infect Dis Clin N Am 2009; 23: 35-52.
30. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG. Body site colonization in patients with communityassociated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2010;16:425-31.
31. Kaplan SL. Commentary: Prevention of recurrent staphylococcal infections. Pediatr Infect Dis J 2008; 27:935-7.
32. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-41.
33. Carrillo-Marquez MA, Hulten KG, Hammerman W, Mason EO, Kaplan SL. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J 2009; 28:1076-80.
34. McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hulten KG. Increase of the USA300 clone among community-acquired methicillinsusceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 2007; 26:1122-7.
35. Chen AE, Carroll KC, Diener-West M, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics 2011; 127:e573-80.